Screened — Not Fully Processed

This study passed a relevance screen (metadata, classification, and summary) during evidence search, but its full analysis (claims, mechanisms, insights) has not been generated yet.

FGF21 analog for obesity and type 2 diabetes

Original Title

The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.

doi:10.1016/j.cmet.2013.08.005